News
Insight
Currencies
Columns
Events
Search
Recently Searched
Hot Coins
Trending
Daily Must-Read
English
English
简体中文
한국어
日本語
Tiếng Việt
ไทย
Türkçe
Русский
Favorites
Follow
Comments
Creator Platform
Settings
Sign Out
SIGN IN
Welcome Back
Sign in with Twitter
Sign in with Discord
Sign in with Google
Sign in with Apple
Sign in with Email
Click “Sign in” to agree to Cointime’s
Terms of Service
and acknowledge that Cointime’s
Privacy Policy
applies to you.
Join CoinTime
Sign up with Twitter
Sign up with Discord
Sign up with Email
Already have an account?
Sign in
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
{route = 'sent-email'})" />
{route = 'sent-email'})" >
Sign in
page.Sign up
All Sign in options
All Sign up options
Check your inbox
Click the link we sent to
to sign in.
Click the link we sent to
to sign up.
OK
Bitcoin
$87,961.56
-2.47%
Ethereum
$3,068.38
-5.07%
BNB
$619.01
-2.49%
Optimism
$1.52
-10.45%
Arbitrum
$0.58
-7.96%
Solana
$209.47
-4.39%
Polygon
$0.36
-6.16%
Cosmos
$5.06
-3.36%
Avalanche
$31.75
-6.68%
Bitcoin
$87,961.56
-2.47%
Ethereum
$3,068.38
-5.07%
BNB
$619.01
-2.49%
Optimism
$1.52
-10.45%
Arbitrum
$0.58
-7.96%
Solana
$209.47
-4.39%
Polygon
$0.36
-6.16%
Cosmos
$5.06
-3.36%
Avalanche
$31.75
-6.68%
Home
/
Karyopharm Therapeutics
/
investors
Karyopharm Therapeutics
company
Investors
Number of Lead Investors
Number of Investors
5
14
Karyopharm Therapeutics is funded by 14 investors.
Avidity Partners
and
Foresite Capital
are the most recent investors.
Investor Name
Lead Investor
Funding Round
Avidity Partners
Yes
Post-IPO Equity
Foresite Capital
Yes
Series B
Chione
Yes
Series A
Multiple Myeloma Research Foundation
Yes
Grant
Adage Capital Management
-
Post-IPO Equity
Armistice Capital
-
Post-IPO Equity
HealthCor Partners
-
Post-IPO Equity
Heights Capital Management
-
Post-IPO Equity
Marshall Wace
-
Post-IPO Equity
Rubric Capital Management
-
Post-IPO Equity
SilverArc Capital
-
Post-IPO Equity
Surveyor Capital
-
Post-IPO Equity
Delphi Ventures
-
Series B
New Leaf Venture Partners
-
Series B
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
Share
{hover = true;if (isWechat) genQrcode($refs.qrcode);}" @mouseleave="hover = false" :style="{'color': platform.color}" >
Wechat scan to share
Page Link
Favorite
Favorite